1. INTRODUCTION {#sec1}
===============

Dendritic cells (DC), known as professional antigen-presenting cells, are involved in the regulation of mucosal immune responses. In peripheral tissues, contact with antigen induces a maturation process and the migration of DC to secondary lymphoid organs, where they induce the differentiation of naïve T cells \[[@B1], [@B2]\]. The induced profile (i.e., Th1, Th2, or regulatory) depends on the nature of the signals received and delivered by DC \[[@B3]\]. In atopic patients, DC play a pivotal role in the development and the maintenance of allergic diseases characterized by a predominant Th2 profile \[[@B3], [@B4]\].

The increased risk of allergic diseases observed in industrialized countries was suggested to be related to western life style characterized by a reduced overall exposure to microbial stimulation in infancy \[[@B5]--[@B7]\]. Postnatal exposure to microbial antigens elicits preferentially Th1 or T regulatory responses, which have been suggested to counterbalance Th2-polarized cytokine production in neonates. Insufficient early microbial exposure may favor the persistence of Th2-type cytokines production allowing the potential development of allergy. The intestine is one of the major immune organs of the body where DC can encounter bacteria \[[@B8], [@B9]\]. The predominant sites of antigen sampling are the Peyer patches, where intestinal DC interact directly with luminal bacteria by passing their dendrites between epithelial tight junctions or after transport of bacteria through M cells \[[@B10], [@B11]\].

Some commensal organisms are used as probiotics, that is, live microbial food ingredients with health-promoting properties \[[@B12]\]. Recent studies suggest that healthy gut microbiota may have a crucial role for the maturation of the immune system to nonallergic mode. The intestinal flora of allergic children is less often colonized with lactobacilli in comparison with nonallergic children \[[@B13]\]. A clinical study demonstrates that perinatal administration of probiotic bacteria (*Lactobacillus* GG) halved the later development of atopic eczema in high-risk children \[[@B14], [@B15]\]. This effect may be due to the anti-inflammatory properties of probiotic bacteria. Consumption of *Lactobacillus* GG by children with atopic dermatitis has been reported to enhance the generation of interleukin (IL)-10 in serum \[[@B16]\]. Moreover oral feeding of mouse with heat-killed *Lactobacillus casei* (strain shirota) inhibited specific IgE production \[[@B17]\]. As DC inhabiting the gut, mucosa are constantly in close vicinity to microorganisms, the intestinal flora may exert regulatory effects through DC modulation. Lactobacilli were reported to regulate mouse DC surface molecule expression and cytokine production \[[@B18]\]. We previously demonstrated that three different LAB strains were able to inhibit the secretion of Th2 cytokines by peripheral blood mononuclear cells from allergic donors \[[@B19]\]. Moreover, we confirmed for one of the strain (*L. plantarum*) the inhibition of the Th2 response induced by Der p 1-pulsed DC from allergic patients in vitro. This was associated with increased IL-12 secretion by DC, reduced Th2 cytokine production (IL-4, IL-5), and increased production of Th1 cytokine (interferon (IFN)-*γ*) by autologous T cells \[[@B20]\].

The presence of LAB in the intestinal environment might be an important factor required to avoid the development of the allergy-associated Th2 response. In view of the critical importance of DC in the regulation of the immune response, we analyzed the reactivity of human monocyte-derived DC to the LAB *L. casei* (ATCC 393) by using a well-defined experimental model of intestinal epithelium. Thus the effect of a *L. casei* strain on activation patterns of DC from allergic and healthy donors was investigated and the impact on T cell-dependent cytokine production was evaluated.

2. MATERIALS AND METHODS {#sec2}
========================

2.1. DC and T lymphocytes preparation {#subsec2.1}
-------------------------------------

### 2.1.1. Donors {#subsubsec2.1.1}

Blood was collected from allergic patients sensitive to house dust mite (specific IgE antibodies; positive skin prick tests towards *Dermatophagoides pteronyssinus* (Dpt) (RAST class \> 3); total serum IgE \> 250 kU/mL) and from healthy donors (total IgE level \<20 kU/L; specific anti-Dpt antibodies \<0.35 kU/L).

### 2.1.2. Cell preparation {#subsubsec2.1.2}

Monocyte-derived DC were generated from blood monocytes purified by positive selection using monoclonal anti-CD14 antibodies coupled to magnetic microbeads (Miltenyi Biotech, Bergsch Gladbach, Germany) as described \[[@B20]\]. Cells were cultured at 1 × 10^6^ cells/ml for 5-6 days in complete medium containing 25 ng/ml granulocyte-macrophage colony stimulating factor (GM-CSF) (Preprotech, London, UK) and 10 ng/ml IL-4 (R&D system, Oxon, UK) to obtain immature DC. At the end of the culture, 95% of the population is CD1a^+^HLA-DR^+^CD80/C86^low^.

Naive CD4^+^ T cells were isolated from the eluted CD14^−^ cell fraction by negative selection using a CD4^+^CD45RA^+^ T cell isolation kit (Miltenyi Biotech, Germany) (purity \> 95%) and frozen until use.

2.2. Caco2-DC Transwell coculture system {#subsec2.2}
----------------------------------------

To mimic the intestinal barrier, we used an in vitro Transwell coculture system as described \[[@B10]\]. Caco2 cell line was grown in Dulbecco\'s MEM (Cambrex Bio Sciences, Verviers, Belgium) supplemented with 10% heat-inactivated fetal calf serum (Invitrogen, Paisley, UK), 1% nonessential amino acid (Gibco BRL, UK), and antibiotics. Cells were seeded on the upper face of 6.5 mm filters (3 *μ*m pore Transwell filters, Corning Incorporated, Acton, MA) for 15 days until a transepithelial resistance (TER) of ∼ 300 Ω/cm^2^ was achieved. Transwell filters were turned upside-down, and immature DC (1 × 10^6^) were added for 3 hr on the filter facing the basolateral membrane of the epithelium to allow cell attachment. Filters were replaced into 24-well plates. TER was checked to be unchanged during the coculture with DC and after *L. casei* stimulation (Grangette personal observation) as described \[[@B21]\].

2.3. Preparation of bacteria {#subsec2.3}
----------------------------

*L. casei* ATCC 393 was prepared as previously described \[[@B20]\]. Briefly, the bacteria were cultured overnight in MRS broth medium (Difco, Detroit, MI), at 37°C. The bacterial suspension was diluted at 1 : 20 in fresh medium and further cultured until exponential phase. After washing, bacteria were resuspended in PBS containing 20% of glycerol and stored at −80°C before using. The bacteria concentration was determined as described \[[@B20]\].

As live and killed LAB were not different in their capacity to regulate peripheral blood mononuclear cells (PBMC) or DC stimulation (\[[@B19], [@B20]\], Grangette personal observation), we used killed LAB obtained after fixation by 45 min incubation in endotoxin-free PBS 4% paraformaldehyde (PFA). These killed LAB were stored at +4°C until use.

2.4. Uptake analysis {#subsec2.4}
--------------------

### 2.4.1. FITC-labelled bacteria {#subsubsec2.4.1}

Fixed bacteria were resuspended in RPMI (1 ml) and incubated with ethanol (2 ml, 70%) for 1 h at room temperature. After centrifugation (2500 g, 15 min), bacteria were suspended in carbonate/bicarbonate (pH = 9.7) buffer and incubated with 0.1 mg/ml fluorescein isothiocyanate (FITC) (Sigma, Germany) for 1 h, with constant stirring. After washing in PBS 0.1% gelatine, bacteria were stored in RPMI at −20°C before use. FITC-labelled bacteria were added on the apical side for 24 or 48 h at the dose of DC/bacteria: 1/10, 1/100. TER were checked to be unchanged during this time.

### 2.4.2. Flow cytometer analysis {#subsubsec2.4.2}

Monocyte-derived DC from allergic (*n* = 2) or healthy (*n* = 2) donors, adherent or not to the filter, were collected and immediately analyzed by FACScalibur (Becton Dickinson, San Diego, CA).

### 2.4.3. Cell staining for confocal microscopy {#subsubsec2.4.3}

After 48 h of culture, Transwell filters were washed and fixed 30 min in PFA (4%). After 15 min treatment with PBS 0.5% Triton (Hopkin & Williams) and 30 min saturation with human serum (2% in PBS), filters were incubated either with monoclonal anti-human CD11c antibody coupled to Phycoerythrin (PE) or with an irrelevant antibody (Becton Dickinson) for 30 min. After washing, filters mounted with Fluoprep (Biomérieux SA, France) were analyzed with confocal laser scanning microscope (SP2 AOBS, LCS software, Leica, Wetzlar, Germany).

The dose of 100 bacteria for 1 DC, allowing the highest uptake intensity in preliminary studies, was chosen for all the experiments with the epithelium (data not shown).

2.5. DC activation {#subsec2.5}
------------------

After 48 h of culture with bacteria, monocyte-derived DC from allergic (*n* = 6) or from healthy (*n* = 7) donors were harvested for phenotype analysis and their supernatants collected. Only one test per individual was performed in each group.

### 2.5.1. DC surface marker analysis {#subsubsec2.5.1}

Monocyte-derived DC adherent or nonadherent to the filter were washed in PBS and incubated for 30 min at 4°C with different monoclonal antibodies (mAbs) : FITC-conjugated anti-CD86, anti-HLA-DR, and PE-conjugated anti-CD80, anti-CD54 or irrelevant mAbs (Becton Dickinson). Cells were fixed in PBS 1% PFA and analyzed using a FACScalibur (Becton Dickinson). Variations in DC phenotype were expressed as the difference between mean fluorescence intensity (MFI) minus the isotype control MFI (ΔMFI).

### 2.5.2. Cytokine production by DC {#subsubsec2.5.2}

DC supernatants were harvested from the lower chamber of the Transwell 48 h following stimulation and assayed for the presence of IL-10 or IL-12 (IL-12 p70) by specific ELISA (Diaclone, France). The sensitivity of both assays was 5 pg/ml.

2.6. T cell activation {#subsec2.6}
----------------------

### 2.6.1. DC-T coculture {#subsubsec2.6.1}

After 24 hours of culture with bacteria, monocyte-derived DC (allergic: *n* = 5; healthy: *n* = 5) activated in the Transwell system and adherent or not to the filter were harvested from the lower chamber ([Figure 1(a)](#F1){ref-type="fig"}). After washing, DC were resuspended in complete RPMI medium (10^5^/ml) and cultured with autologous CD4^+^CD45RA^+^ T cells (10^6^/ml) (ratio: 1 DC/10 T lymphocytes) for 5 days. Only one test per individual was performed in each group.

### 2.6.2. Cytokine production by T cells {#subsubsec2.6.2}

Supernatants were collected and assayed for IL-5 (PharMingen), IL-10, and IFN-*γ* (Diaclone) by specific ELISA (sensitivity = 5 pg/ml).

2.7. Statistical analysis {#subsec2.7}
-------------------------

Nonparametric statistical analyses were performed with paired samples and the permutation tests (STATEXACT, Cytel Software, MA). *P* values of .05 or less were considered statistically significant.

3. RESULTS {#sec3}
==========

3.1. DC are able to capture L. casei through the intestinal epithelium {#subsec3.1}
----------------------------------------------------------------------

To evaluate the uptake of lactic acid bacteria (LAB) by DC through a human intestinal epithelium, DC from healthy or allergic donors were incubated with FITC-labelled *L. casei* for 24 or 48 hours in the Transwell coculture system. DC adherent and nonadherent to the filter were harvested and analyzed separately. The number of DC adherent to the filter was slightly increased with DC from healthy donors compared to allergic patients after *L. casei* stimulation (59800 ± 28200 and 33900 ± 2200 adherent cells per well, resp.), whereas unstimulated DC from healthy and allergic donors similarly adhere to epithelium (20417 ± 4641 and 17000 ± 5778, resp.). Both in allergic and healthy donors, the capture of FITC-bacteria by DC directly adherent to the epithelium increased between 24 and 48 h. In contrast, nonadherent DC captured fewer bacteria and only at 48 h. For the analyzed donors, the uptake of *L. casei* by DC was lower for allergic compared to healthy donors ([Figure 2](#F2){ref-type="fig"}). Higher percentages of FITC-positive cells were detected when DC were directly incubated with bacteria, without epithelium (data not shown).

The bacteria uptake through the intestinal epithelium was further confirmed by confocal microscopy. Different sections of the same adherent DC detected with an anti-CD11c antibody ([Figure 1(a)](#F1){ref-type="fig"}) clearly showed a colocalization of FITC-labelled *L. casei* into the DC cytoplasm ([Figure 1(b)](#F1){ref-type="fig"}).

3.2. DC acquire a moderate maturation status upon L. casei stimulation through the intestinal epithelium {#subsec3.2}
--------------------------------------------------------------------------------------------------------

To determine whether maturation of DC by *L. casei*, in the presence of the epithelium, is associated with phenotypic changes; the expression of CD80, CD86, HLA-DR, and CD54 (intercellular adhesion molecule (ICAM)-1) was assessed. *L. casei* induced a low increase in the expression of the costimulatory molecules CD86 (*P* \< .05 for adherent and nonadherent DC from allergic patients) and CD54 (*P* \< .05 for adherent DC from allergic donors) on DC from healthy and allergic donors, whether they were adherent or not to the epithelium. The expression of MHC II (HLA-DR) and CD80 was not modified by the stimulation with *L. casei* on DC from both allergic and healthy donors ([Figure 3](#F3){ref-type="fig"}). These results suggest that *L. casei* induces a moderate maturation of DC in presence of the epithelium.

3.3. Cytokine production by L. casei-stimulated DC {#subsec3.3}
--------------------------------------------------

The production of IL-10 and IL-12, involved in the orientation of the immune response, was analyzed. DC from healthy donors incubated with *L. casei* significantly produced IL-10 and IL-12 48 h after the stimulation, with similar levels in the presence or in the absence of the intestinal epithelium ([Figure 4(a)](#F4){ref-type="fig"}). In contrast, DC from allergic patients incubated with *L. casei* only slightly increased IL-10 and IL-12 production in the absence of the epithelium, whereas the secretion of these two cytokines was amplified in the presence of the epithelial layer (*P* \< .05) ([Figure 4(b)](#F4){ref-type="fig"}), suggesting a role of the epithelium in the *L. casei*-induced cytokine production by DC from allergic donors.

3.4. Cytokine production by naive CD4^+^ T cells {#subsec3.4}
------------------------------------------------

To evaluate the effect of *L. casei* on the orientation of the response induced by DC from allergic and healthy donors, the production of IFN-*γ* (Th1 cytokine), IL-5 (Th2 cytokine), and IL-10 (cytokine produced by some regulatory T cells) by autologous naive T cells was analyzed. As no differences were detected in the maturation status between adherent and nonadherent DC and as *L. casei* capture was more efficient in adherent DC, adherent DC were chosen for T cell stimulation.

Without epithelium, *L. casei* mainly increased the IFN-*γ* production by naive T cells instructed by DC from healthy donors (62.40 ± 34.88 compared to 39.45 ± 26.13 for medium condition). IL-5 and IL-10 production by T cells was less increased. No increase in these cytokine levels was detected with *L. casei*-activated DC from allergic donors. In healthy donors, the sole presence of Caco2 epithelial layer (without *L. casei* stimulation) decreased the IFN-*γ* production by DC-instructed T cells (5.35 ± 5.58 ng/ml with the epithelium compared to 39.45 ± 26.13 ng/ml without the epithelium). In contrast, for all cytokine production, the increase induced by *L. casei*-stimulated DC from healthy or allergic donors was further enhanced if DC were conditioned by the epithelium. The increase in cytokine production for T cells activated by *L. casei*-stimulated DC was more pronounced for IFN-*γ* (26.75 ± 8.02 ng/ml for the *L. casei* condition compared to 9.72 ± 10.41 ng/ml for the medium condition for allergic patients; 48.60 ± 16.68 ng/ml for the *L. casei* condition compared to 5.35 ± 5.58 ng/ml for healthy donors). The increase in cytokine production for allergic donors reached similar levels to healthy donors for IL-5 and IL-10, whereas IFN-*γ* levels remained higher for healthy donors ([Figure 5](#F5){ref-type="fig"}).

4. DISCUSSION {#sec4}
=============

The mucosal immune system is continuously exposed to dietary and microbial antigens and needs to react with appropriate immune responses. Compelling evidence suggested that appropriate microbial colonization of the gut is important in providing signals to prevent the overexpression of Th2-dominated atopic responses \[[@B22]\]. In the last few years, the potential role of selected probiotic strains in the prevention of allergic diseases has become more evident. Nevertheless the mechanism underlying these properties remains unknown. Intestinal epithelial cells permanently interact with the luminal content, including the commensal flora, and the cellular network of immune cells. Because of their location at mucosal sites and their implication in the initiation of the immune reaction, DC play a key role in this process. In order to evaluate the involvement of DC intestinal environment on their function, we used a well-established model of epithelial cells and DC coculture \[[@B10], [@B21], [@B23]\]. We analyzed the effect of a selected *L. casei* strain, which was previously demonstrated to reduce allergen-specific Th2 secretion in vitro \[[@B20]\]. In the present study, we demonstrated that monocyte-derived DC from healthy or allergic donors take up nonpathogenic *L. casei* through an intestinal epithelium. The analysis of the FITC-bacteria uptake in the Transwell model showed that the process is time-dependent, increasing between 24 and 48 h, and higher in healthy donors compared to allergic ones. The number of DC which have captured bacteria through the epithelium was low even after 48 h in comparison with DC directly interacting with *L. casei* (without the epithelium). Using fluorescent beads, we checked that beads incubated in the upper chamber did not pass through the epithelium. Moreover, because no change in TER was observed, we hypothesize that in our conditions DC open tight junctions and sample bacteria by extending their dendrites through the epithelium without disrupting epithelial integrity as it was previously demonstrated in the same model \[[@B10]\]. This active process may explain the time required to capture bacteria efficiently in the presence of the epithelium. By confocal analysis, we clearly confirmed the bacteria uptake by DC as *L. casei* colocalized with adherent DC.

By producing cytokines and/or by expressing specific costimulatory molecules, DC can modulate the development of T cell response and are considered as pivotal cells in the development or the limitation of the allergic reaction. DC phenotype and functions are dependent upon their mucosal environment. In particular, intestinal epithelial cells condition DC to become "noninflammatory" in vitro and may be involved in their capacity to maintain gut homeostasis \[[@B21], [@B24]\]. Here we showed that DC from both allergic and healthy donors acquired an intermediate maturation status characterized by a moderate expression of cell-surface costimulatory molecules and maturation markers upon stimulation with *L. casei* in the presence of the intestinal epithelium. This intermediate maturation status has previously been described in different experimental settings. The ability of two Gram-positive bacteria, pathogenic *Streptococcus pyogenes,* and nonpathogenic *Lactobacillus rhamnosus* to induce monocyte-derived DC maturation has been compared. *S. pyogenes* was shown to be a more potent stimulator of DC maturation than *L. rhamnosus*. Indeed, this lactic acid bacteria induced a partial DC maturation, as evidenced by the moderate expression of costimulatory molecules CD80, CD83, and CD86 and a weak cytokine and chemokine response \[[@B25]\]. The same observations were reported with activation by direct contact of human DC by a Gram-negative pathogenic bacteria compared to *L. rhamnosus* and with activation of murine DC with various strains of Lactobacilli \[[@B18], [@B26]\]. Similarly, in a model of intestinal epithelium, activation with *L. plantarum* induced a lower expression of CD80 and CD83 compared with activation with Gram-negative pathogenic bacteria \[[@B24]\]. As costimulatory molecules are involved in contact between DC and T cells during antigen presentation, a moderate expression of these molecules may result in orientation toward a T regulatory pathway \[[@B27]\].

The cytokine microenvironment plays a critical role during T cell polarization. For example, IL-12 is important to skew T cell differentiation towards Th1-type response, and IL-10 is associated with immunoregulatory processes \[[@B28], [@B29]\]. Here we showed that *L. casei*-induced IL-10, and IL-12 production by DC from allergic donors was lower compared to healthy donors, which may be related to a lower adherence to the epithelium and a lower number of DC which have captured *L. casei*. However, as this lower production of IL-10 and IL-12 by DC from allergic donors was also obtained after *L. casei* stimulation in the absence of the epithelium, this suggests a dysfunction of DC from allergic compared to healthy donors. Both cytokines were shown to be produced by murine DC stimulated by a mixture of bifidobacteria and lactobacilli (VSL\#3) \[[@B30]\]. We also noticed that, in the presence of the intestinal epithelium, DC from allergic patients produced higher levels of IL-12 and IL-10 compared to cells directly in contact with bacteria. The interactions of *L. casei* with epithelial cells might have an effect on IL-12 and IL-10 secretion by DC from allergic patients, therefore balancing the potential defect in their production. Indeed, some mediators released by epithelial cells might induce "noninflammatory DC," which contribute to maintain gut immune homeostasis, and limit excessive inflammatory reactions like allergy \[[@B31]\]. Consequently, in allergic patients, stimulation with nonpathogenic *L. casei* associated with the anti-inflammatory effect of the epithelium might favor the development of semimature DC, characterized by moderate expression of costimulatory molecules and low cytokine production that could counterbalance the Th2-biased immune response \[[@B27], [@B32]\].

T cell activation and polarization of the immune response may be influenced by DC maturation status and DC cytokine production induced by *L. casei*. In the present study, we showed that the epithelium increased the cytokine production by autologous T cells instructed by *L casei*-activated DC derived from healthy and allergic donors, and especially the IFN-*γ*. Increased IFN-*γ* induced by LAB has previously been shown in a system of direct contact with bacteria using DC from allergic and healthy donors \[[@B20], [@B33]\]. In vivo, another LAB strain (*L. plantarum*) exhibited Th1 promoting capacity in a murine model of birch pollen allergy \[[@B34]\]. IL-5 and IL-10 production were measured to analyze the effect of LAB activation on the Th2 or on the immunoregulatory responses, respectively. *L. casei*-pulsed adherent DC conditioned by the intestinal epithelium moderately increased the secretion of IL-5 and IL-10 in both allergic and healthy donors. The increase in IL-5 production is in agreement with a previous study using DC derived from healthy donors and activated by *L. plantarum* in the presence of an intestinal epithelial monolayer \[[@B24]\]. However, in the absence of the epithelium, *L. plantarum* has been shown to reduce the Th2 response induced by DC from allergic donors stimulated by the relevant allergen; whilst it did not modify the response in healthy donors \[[@B20]\]. This suggests that LAB may differentially regulate the immune response according to their environment. Selective lactobacilli strains (*L. casei* and *L. reuteri*) have been demonstrated to drive the generation of regulatory IL-10^+^ T cells through DC activation in vitro \[[@B35]\]. Moreover, *L. rhamnosus* has been shown to induce a peripheral hyporesponsiveness in stimulated CD4^+^ T cells \[[@B36]\]. IL-10 is a cytokine known to limit an inflammation due to IFN-*γ* or IL-5 production. Even though, in our experiment, the moderate increased secretion of IL-10 in the coculture of T cells with *L. casei*-pulsed adherent DC may be due to increased production by DC, the balance between IL-10 and IFN-*γ* or IL-5 might regulate potential immune regulatory pathways. Thus, strains of lactobacilli might differentially affect DC and lead to the development of different T cell responses but each mechanism seems to control the immune homeostasis. Moreover, although DC nonadherent to the filter, that is, not in direct contact with the epithelium, exhibited a similar maturation status compared to adherent DC, nonadherent DC from both allergic and healthy donors failed to increase T cell cytokine production upon *L. casei* stimulation (data not shown). These results indicate that the epithelium plays a role in the capacity of *L. casei*-activated DC to regulate T cells, even though the sole presence of the epithelium decreases the Th1 response as previously demonstrated \[[@B31]\]. DC in contact with *L. plantarum* and epithelial cells in the Transwell model have been shown to be more "inflammatory" because of their capacity to release IL-12, IL-10 and to promote T cell proliferation, compared to DC activated only by epithelial mediators \[[@B24]\]. The crosstalk between epithelial cells, DC, and LAB might allow on the one hand the establishment of a protective effect against any antigen encountered, vital for combating pathogenic organisms, and on the other hand the limitation of potentially damaging inflammatory immune reactions against endogenous microflora.

In conclusion, our results demonstrate efficient interactions between *L. casei* and DC through the intestinal epithelium. By modulating DC function and by preserving its capacity to react against harmful pathogenic organisms, *L. casei* may contribute to maintain the homeostasis of the gut immune system. Finally, by limiting inappropriate immune activation, *L. casei* might prevent or reduce inflammatory responses such as the development of an allergic inflammatory response.
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*Confocal analysis of FITC-labelled L. casei uptake by adherent DC*. (a) Schematic view of the DC/epithelial cell culture model. The dotted arrow indicates the section where the analysis was done. (b) The pictures represent different sections of the same DC and show the colocalization of FITC-bacteria into the cytoplasm of DC.
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![*DC take up FITC-labelled L. casei through an intestinal epithelial layer*. Monocytes from allergic patients and healthy donors were differentiated in DC in the presence of GM-CSF and IL-4 for 5-6 days. Cells were then pulsed with unlabelled or with FITC-labelled *L. casei* (ratio bacteria/DC: 100/1) for 24 or 48 hours in the presence of an intestinal epithelial layer. DC, adherent and nonadherent to the filter, were harvested and analyzed by flow cytometry. (a) The percentage of FITC-positive cells is evaluated into the gate represented on the dot plots. (b) Open histograms represent the fluorescence of DC incubated with unlabelled *L. casei*, and closed histograms represent the capture of FITC-labelled *L. casei* by DC. The percentages of FITC-positive cells are indicated. One representative experiment is shown for both donor types.](JBB2007-71921.002){#F2}

![*Effect of L. casei stimulation on DC phenotype*. Monocyte-derived dendritic cells from house dust mite sensitive-patients (a) and (b) and from healthy donors (c) and (d) were exposed (dark grey line) or not (grey line) to *L. casei* for 48 hours in the Transwell model. (a) and (c) Adherent DC were analyzed by flow cytometry for CD80, CD86, HLA-DR, and CD54 expression. the black line represents the reactivity of fluorochrome-matched isotype control mAbs. One representative experiment (out of 6 and 7, for allergic and healthy donors, resp.) is shown. (b), (d) The mean fluorescence intensity (ΔMFI) of the expression of each marker by adherent and nonadherent DC after stimulation with medium, and *L. casei* is represented for both allergic ((b), *n* = 6) and healthy donors ((d), *n* = 7). \**P* \< .05.](JBB2007-71921.003){#F3}

###### 

*L. casei-stimulated DC produce IL-12 and IL-10*. Monocytes-derived DC from healthy (a) and allergic (b) donors were pulsed or not for 48 hours with *L. casei* through an intestinal epithelial layer or not. Supernatants were collected and the amounts of IL-10 and IL-12 were measured by specific ELISA. Results are expressed as mean ± SEM (*n* = 5 for allergic donors and *n* = 5 healthy donors). \**P* \< .05.
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![*Production of cytokine by naïve CD4^+^ T cells*. Monocyte-derived DC from allergic patients and healthy donors were incubated with *L. casei* or medium only for 24 hours, either directly in contact with cells (without epithelium) or through an intestinal epithelial layer (with epithelium). Adherent DC were harvested from the lower chamber of the Transwell, cultured with naïve autologous CD4^+^ T cells for 5 days. Supernatants were collected and the amounts of IFN-*γ*, IL-10, and IL-5 were measured by specific ELISA. Results are expressed as mean ± SEM of cytokine percentage increase above *L. casei* stimulation (*n* = 5 for both allergic and healthy donors).](JBB2007-71921.005){#F5}
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